| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.18 | 0.03 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |